Table 1.
Overview of novel approaches having been established for microbial production of RNA molecules
Approach | Target RNA | Bacterial strain | Vector | Promoter | Purification method | Yield (mg/L culture) | References |
---|---|---|---|---|---|---|---|
tRNA scaffold | Various | E. coli JMlOlTr E. coli BL21 (DE3) | pBSTNAV derivative or pET23b | lpp or T7 | PAGE, affinity or ion exchange FPLC | Tens | Nelissen et al. 2012; Ponchon et al. 2009; Ponchon and Dardel 2007 |
rRNA scaffold | Aptamers, sRNAs | E. coli JM109 (DE3) | pCV and pCR derivatives | rrnB P1/P2 | Gel electrophoresis | 2–8 mg/g cells | Liu et al. 2010 |
tRNA/pre-miRNA carrier | Various | E. coli HST08 and DH5a | pBSTNAV | lpp | Spin column, FPLC methods, etc. | Tens | Chen et al. 2015; Ho et al. 2018; Li et al. 2015; Petrek et al. 2019 |
ELVd RNA carrier | Aptamer, sRNA | E. coli BL21 or derivative | P15tRnlSm andpLELVd-BZB | lpp | PAGE, FPLC | ~150 (estimated; total ELVd RNAs) | Daros et al. 2018 |
siRNA binding protein (pl9) | siRNA | E. coli T7 Express Iq (BL21derivative) | pRSF-GST-p19-His and pCDF-GST-p19-His | tac (p19) and T7 (siRNA) | Affinity chromatograph and anion exchange HPLC | ~0.04 | Huang et al. 2013 |
Using RNase III-deficient C. glutamicum | U1A*-RNA diapl *-dsRNA | C. glutamicum 2256LΔrnc | pVH2 | F1 | (Not reported or demonstrated) | Up to 75–300 | Hashiro et al. 2019a; Hashiro et al. 2019b |